Early-onset Dementia

Gene: CYLD

Amber List (moderate evidence)

CYLD (CYLD lysine 63 deubiquitinase)
EnsemblGeneIds (GRCh38): ENSG00000083799
EnsemblGeneIds (GRCh37): ENSG00000083799
OMIM: 605018, Gene2Phenotype
CYLD is in 4 panels

2 reviews

Bryony Thompson (Royal Melbourne Hospital)

I don't know

Original study (PMID: 32185393) identified a gain of function missense segregating 7 FTD cases (1 also with ALS) and 1 ALS case in an Australian family, that has a previously identified linkage peak in this region. Extensive genomic studies were conducted to exclude structural variation and repeats as causes. Supporting immunohistochemical evidence in brain tissue and extensive in vitro assays on the missense variant (M719V), showing a different mechanism of disease to loss of function that is associated with cutaneous phenotypes. Also, demonstrated a significant enrichment of rare missense variants in the deubiquitinase domain of CYLD (amino acids 593–948) in an FTD cohort, but not an ALS cohort. A subsequent Portuguese FTD study has identified two missense VUS in 2 FTD cases. Segregation studies or functional studies were not conducted (PMID: 32666117).
Created: 12 Aug 2020, 12:38 a.m. | Last Modified: 12 Aug 2020, 12:38 a.m.
Panel Version: 0.56

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
frontotemporal dementia; amyotrophic lateral sclerosis

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Red List (low evidence)

Recent report of a missense variant segregating in 1 family with frontotemporal dementia and amyotrophic lateral sclerosis. Functional studies showed that the variant resulted in a gain of ubiquitinase function, opposite from the mechanism causing the well-documented cutaneous phenotypes
Sources: Literature
Created: 21 Apr 2020, 3:27 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Frontotemporal dementia and/or amytrophic lateral sclerosis 8, MIM# 619132

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Frontotemporal dementia and/or amytrophic lateral sclerosis 8, MIM# 619132
OMIM
605018
Clinvar variants
Variants in CYLD
Penetrance
None
Publications
Panels with this gene

History Filter Activity

16 Jan 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: CYLD were changed from Frontotemporal dementia; Amyotrophic lateral sclerosis to Frontotemporal dementia and/or amytrophic lateral sclerosis 8, MIM# 619132

12 Aug 2020, Gel status: 2

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: cyld has been classified as Amber List (Moderate Evidence).

21 Apr 2020, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: cyld has been classified as Red List (Low Evidence).

21 Apr 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: CYLD was added gene: CYLD was added to Early-onset Dementia. Sources: Literature Mode of inheritance for gene: CYLD was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: CYLD were set to 32185393 Phenotypes for gene: CYLD were set to Frontotemporal dementia; Amyotrophic lateral sclerosis Review for gene: CYLD was set to RED